Core Insights - Catheter Precision, Inc. is participating in three upcoming medical conferences to showcase its products, particularly the LockeT device and VIVO system [1][2][9] - The LockeT device has demonstrated clinical advantages over manual compression in a study involving 97 patients, including reduced time to ambulation and lower costs [1][4] - VIVO is a non-invasive 3D imaging system that aids in identifying the origin of ventricular arrhythmias, enhancing workflow and reducing procedure time [5] Conference Participation - Catheter Precision will attend the American College of Cardiology (ACC) meeting from March 29-31, 2025, where the LockeT device will be featured [9] - The company will also have a presence at the European Heart Rhythm Association (EHRA) and Society of Interventional Radiology (SIR) conferences, marking its first participation in an interventional radiology event [2][9] Product Highlights - LockeT is a Class 1 FDA-registered suture retention device designed for wound closure after percutaneous venous punctures [6] - VIVO has received marketing clearance from the U.S. FDA and holds a CE mark, indicating its regulatory approval for use [5] Company Overview - Catheter Precision is focused on developing innovative solutions for cardiac arrhythmias, emphasizing collaboration with physicians to advance its product offerings [7]
Catheter Precision to Participate in and Share Data at Upcoming Industry Conferences